Organogenesis Holdings Inc.
Pharmaceutical Preparations · Canton, MA, United States
- PrincipalsAntonio S. MontecalvoVice President, Health PolicyBrian GrowChief Commercial OfficerDavid FranciscoChief Financial Officerand 13 more
- CompanyOrganogenesis Holdings Inc.Canton, MA, United States
- Phone line+1 (781) 575-0775General business
Organogenesis Holdings Inc. is an SEC-registered Nasdaq-listed company (ticker ORGO) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 16
Chief executive
Gary S. GillheeneyPresident and CEO
Chair & board
Arthur S LeibowitzDirector (Board)
Garrett LustigDirector (Board)
Gilberto QuinteroDirector (Board)
Glenn H NussdorfDirector (Board)
Operations
Patrick BilboChief Operating Officer
Sales & commercial
Brian GrowChief Commercial Officer
Legal
Lori FreedmanChief Admin. and Legal Officer
Everyone else on file (2)
Antonio S. MontecalvoVice President, Health Policy
Robert CavorsiVice President, Strategy
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Antonio S. Montecalvo — Vice President, Health Policy
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Brian Grow — Chief Commercial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David Francisco — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Gary S. Gillheeney — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIIRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityPl. VIIBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityPl. VIIInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityPl. VIIXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityPl. VIIPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityPl. VIIMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityPl. VIIenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityPl. VIIEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capability